Perioperative chemotherapy for resectable colorectal liver metastases: Where now?

European Journal of Surgical Oncology

Volumn 39, Issue 8, 2013, Pages 807-811

  Jones, R P ^a,b   Malik, H Z ^b   Fenwick, S W ^b   Poston, G J ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Chemotherapy; Colorectal; Liver

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; COLORECTAL LIVER METASTASIS; HEALTH CARE QUALITY; HUMAN; LIVER RESECTION; LIVER SURGERY; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; REVIEW; TREATMENT OUTCOME;

CHEMOTHERAPY; COLORECTAL; LIVER;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PERIOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84879840955     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.04.002     Document Type: Review

References (50)

1. J. Scheele, R. Stang, A. Altendorf-Hofmann, and M. Paul Resection of colorectal liver metastases World J Surg 19 1 1995 59 71
2. H. Yamada, S. Kondo, S. Okushiba, T. Morikawa, and H. Katoh Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases World J Surg 25 9 2001, Sep 1129 1133
3. P.J. Crowe, J.L. Yang, and C.R. Berney Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer World J Surg 25 8 2001, Aug 996 1001
4. T. Mala, G. Bøhler, Mathisen, A. Bergan, and O. Søreide Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 26 11 2002, Nov 1348 1353
5. M.A. Choti, J.V. Sitzmann, and M.F. Tiburi Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 6 2002, Jun 759 766
6. B. Nordlinger, J.C. Vaillant, and M. Guiguet Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie J Clin Oncol 12 7 1994, Jul 1491 1496
7. J. Figueras, C. Valls, A. Rafecas, J. Fabregat, E. Ramos, and E. Jaurrieta Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases Br J Surg 88 7 2001, Jul 980 985
8. M. Rees, P.P. Tekkis, F.K.S. Welsh, T. O'Rourke, and T.G. John Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 1 2008, Jan 125 135
9. J.Y. Wang, J.M. Chiang, L.B. Jeng, C.R. Changchien, J.S. Chen, and K.C. Hsu Resection of liver metastases from colorectal cancer: are there any truly significant clinical prognosticators? Dis Colon Rectum 39 8 1996, Aug 847 851
10. H.J. Wanebo, Q.D. Chu, M.P. Vezeridis, and C. Soderberg Patient selection for hepatic resection of colorectal metastases Arch Surg 131 3 1996, Mar 322 329
11. S. Ambiru, M. Miyazaki, and T. Isono Hepatic resection for colorectal metastases: analysis of prognostic factors Dis Colon Rectum 42 5 1999, May 632 639
12. J. Scheele, R. Stangl, A. Altendorf-Hofmann, and F.P. Gall Indicators of prognosis after hepatic resection for colorectal secondaries Surgery 110 1 1991, Jul 13 29
13. G. Folprecht, A. Grothey, S. Alberts, H.-R. Raab, and H. Köhne C- Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Ann Oncol 16 8 2005, Aug 1311 1319
14. R.P. Jones, R. Jackson, and D.F.J. Dunne Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases Br J Surg 99 4 2012, Jan 1 477 486
15. G. Chong, and D. Cunningham J Clin Oncol 23 36 2005, Dec 12 9063 9066
16. L.M. Ellis, S.A. Curley, and A. Grothey Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab J Clin Oncol 23 22 2005, Aug 8 4853 4855
17. NCCN Colon cancer guidelines v 3 2012 Available at: http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp [accessed November 2012]
18. G.J. Poston, D. Tait, S. O'Connell, A. Bennett, S. Berendse On behalf of the Guideline Development Group Diagnosis and management of colorectal cancer: summary of NICE guidance BMJ 343 2011, Nov 11 (nov09):d6751
19. G. Portier, D. Elias, and O. Bouche Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial J Clin Oncol 24 31 2006, Nov 11 4976 4982
20. E. Mitry, A.L.A. Fields, and H. Bleiberg Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials J Clin Oncol 26 30 2008, Oct 10 4906 4911
21. M. Ychou, W. Hohenberger, and S. Thezenas A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer Ann Oncol 20 12 2009, Dec 1964 1970
22. E.J.A. Morris, D. Forman, and J.D. Thomas Surgical management and outcomes of colorectal cancer liver metastases Br J Surg 97 7 2010 1110 1118
23. R. Adam, V. Delvart, and G. Pascal Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 4 2004, Oct 644 657
24. A. Wein, C. Riedel, and W. Brückl Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer Oncology 64 2 2003 131 138
25. J. Taïeb, P. Artru, and F. Paye Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study J Clin Oncol 23 3 2005, Jan 1 502 509
26. B. Gruenberger, D. Tamandl, and J. Schueller Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer J Clin Oncol 26 11 2008, Apr 4 1830 1835
27. R. Adam, A. Frilling, and D. Elias Liver resection of colorectal metastases in elderly patients Br J Surg 97 3 2010, Mar 366 376
28. B. Nordlinger, H. Sorbye, and B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC intergroup trial 40983): a randomised controlled trial Lancet 371 9617 2008, Mar 3 1007 1016
29. B. Nordlinger, J.-N. Vauthey, G. Poston, S. Benoist, P. Rougier, and E. Van Cutsem The timing of chemotherapy and surgery for the treatment of colorectal liver metastases Clin Colorectal Cancer 9 4 2010, Oct 212 218
30. B. Nordlinger, E. Van Cutsem, and T. Gruenberger Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel Ann Oncol 20 6 2009, Jun 985 992
31. B. Nordlinger EORTC liver metastases intergroup randomized phase III study 40983; long-term survival results J Clin Oncol 7 30 2012, Jul Abstr 3508
32. R. Adam, R.J. de Haas, and D.A. Wicherts Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery? Ann Surg 253 2 2011, Feb 349 359
33. M.C. de Jong, S.C. Mayo, and C. Pulitano Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis J Gastrointest Surg 13 12 2009, Dec 2141 2151
34. T. Ruers, C. Punt, and F. Van Coevorden Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC intergroup phase II study (EORTC 40004) Ann Oncol 23 10 2012, Oct 2619 2626
35. A.A. Parikh, B. Gentner, T.-T. Wu, S.A. Curley, L.M. Ellis, and J.-N. Vauthey Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy J Gastrointest Surg 7 8 2003, Dec 1082 1088
36. F.G. Fernandez, J. Ritter, J.W. Goodwin, D.C. Linehan, W.G. Hawkins, and S.M. Strasberg Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases J Am Coll Surg 200 6 2005, Jun 845 853
37. L. Rubbia-Brandt, V. Audard, and P. Sartoretti Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol 15 3 2004, Mar 460 466
38. Y. Parc, L. Dugué, O. Farges, K. Hiramatsu, A. Sauvanet, and J. Belghiti Preoperative systemic 5-fluorouracil does not increase the risk of liver resection Hepatogastroenterology 47 36 2000 1703 1705
39. P. Ryan, S. Nanji, and A. Pollett Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy Am J Surg Pathol 34 6 2010, Jun 784 791
40. J.-N. Vauthey, T.M. Pawlik, and D. Ribero Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 13 2006, May 5 2065 2072
41. F.K.S. Welsh, H.S. Tilney, P.P. Tekkis, T.G. John, and M. Rees Safe liver resection following chemotherapy for colorectal metastases is a matter of timing Br J Cancer 96 7 2007, Apr 4 1037 1042
42. D. Tamandl, M. Klinger, and S. Eipeldauer Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy Ann Surg Oncol 18 2 2011, Feb 421 430
43. Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 3 1999, Sep 309 318 [discussion 318-21]
44. A. Carrato Adjuvant treatment of colorectal cancer Gastrointest Cancer Res 2 Suppl. 4 2008, Jul S42 S46
45. G. Folprecht, T. Gruenberger, and W.O. Bechstein Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Lancet Oncol 11 1 2010, Jan 38 47
46. C. Garufi, A. Torsello, and S. Tumolo Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial Br J Cancer 103 10 2010, Nov 11 1542 1547
47. C.-H. Köhne Efficacy of chemotherapy and cetuximab according to metastatic site in KRAS wild-type metastatic colorectal cancer: analysis of CRYSTAL and OPUS studies Ann Oncol 22 Supplement Suppl. 5 2011, Jun 6 abstr O-0002
48. R.P. Jones, J.-N. Vauthey, and R. Adam Effect of specialist decision-making on treatment strategies for colorectal liver metastases Br J Surg 99 9 2012, Sep 1263 1269
49. UK National Institute of Clinical Excellence(NICE). Colorectal cancer quality standard. Available at: http://www.nice.org.uk/guidance/ qualitystandards/indevelopment/ColorectalCancer.jsp [accessed November 2012].
50. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 17 2004, Oct 10 1731 1740